According to Lipella Pharmaceuticals's latest financial reports the company has S$1.8 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | S$4.35 M | -36.65% |
2022-12-31 | S$6.86 M | 196.25% |
2021-12-31 | S$2.31 M | 188.74% |
2020-12-31 | S$0.8 M |